hypoglycemic agents
NEED FOR NEW HYPOGLYCEMIC AGENTS: AN OVERVIEW
... Oral hypoglycemic agents are also useful in the treatment of type 2 ...Oral hypoglycemic agents include sulphonylureas, biguanides, meglitinide, DPP-IV inhibitors, α- glucosidase inhibitors, ...
6
A STUDY ON DRUG UTILIZATION PATTERN OF ORAL HYPOGLYCEMIC AGENTS IN TYPE-2 DIABETIC PATIENTS OF A TERTIARY CARE TEACHING HOSPITAL
... On the basis of our study, we concluded that the most commonly prescribed oral hypoglycemic agents was Metformin in mono and dual therapies and it is also prescribed with Insulin as a combination therapy. ...
8
PHARMACOECONOMICAL EVALUATION OF ORAL HYPOGLYCEMIC AGENTS FOR TYPE 2 DIABETES MELLITUS IN A MULTISPECIALITY HOSPITAL
... oral hypoglycemic agents will reduce the healthcare burden on patients with Diabetes mellitus and reduces the total health expenditure of the country 3-5 ...
6
Molecular Docking and Synthesis of Some Substituted Sulphonylurea/Pyrrolidine Based Derivatives as Hypoglycemic Agents
... The 4th position of derivatives substituted with F and NO2, which was shown better result compare to unsubstituted or substituted with other derivatives. Subsequently, in vivo biological evaluation compound 5B (F), 5G ...
9
Design, synthesis and biological evaluation of some substituted sulphonyl urea/ guanidine derivatives as hypoglycemic agents
... as hypoglycemic agents based on the indirect molecular modeling approach by checking the superimposibility of the design molecule and reported compound n-(6-substituted-1,3- benzothiazol-2-yl)benzene ...
9
Design, synthesis and biological evaluation of some substituted sulphonyl urea/ guanidine derivatives as hypoglycemic agents
... as hypoglycemic agents based on the indirect molecular modeling approach by checking the superimposibility of the design molecule and reported compound n-(6-substituted-1,3- benzothiazol-2-yl)benzene ...
9
IDENTIFICATION, ASSESSMENT AND ANALYSING THE COST EFFECTIVENESS OF ORAL HYPOGLYCEMIC AGENTS FOR PHARMACOECONOMIC EVALUATION IN A TERTIARY CARE TEACHING HOSPITAL
... oral hypoglycemic agents were included in the ...oral hypoglycemic agents, the most cost-effective drug or combination in the hospital was ...oral hypoglycemic monotherapy and Metformin ...
14
Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
... Cox regression analysis was performed to investigate the pre- dictive factors for resumption of insulin therapy for glucose control in subjects who switched to OHAs from initial insulin therapy (Group IA vs. Group IB) ...
9
SAFETY OF INSULIN ADD ON THERAPY AND ORAL HYPOGLYCEMIC AGENTS (OHGAs) POLYPHARMACY IN TYPE II DIABETES PATIENTS A PROSPECTIVE OBSERVATIONAL STUDY
... Oral Hypoglycemic Agents (OHGAs) polypharmacy and to promote safe use of insulin and OHGAs in Type II Diabetes patients, through patient counseling by Clinical pharmacist at Government General Hospital, ...
14
Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis
... Ultimately, the net impact of glyburide on tumor cells remains poorly understood.(15) The current literature evaluating the impact of glyburide (and sulfonylureas in general) on cancer incidence and cancer-related ...
21
Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis
... The effect of cumulative duration of exposure to hypogly- cemic medications before and after NMIBC on the risk of OS was assessed using Cox proportional hazards model, whereas a proportional subdistribution hazard model ...
8
INCIDENCE OF ADVERSE DRUG REACTIONS AND DRUG INTERACTIONS OF ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETIC PATIENTS AT GUWAHATHI MEDICAL COLLEGE HOSPITAL
... To determine the incidence of adverse drug reactions and drug inter- actions due to oral hypoglycemic agents in patients suffering from type 2 diabetes. Methodology: Prior to the conduction of study, ap- ...
8
Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City
... Introduction: Worldwide, diabetes mellitus presents a high burden for individuals and society. In Latin America, many people with diabetes have limited access to health care, which means that indirect costs may exceed ...
9
Utilization Pattern of Oral Hypoglycemic Agents for Diabetes Mellitus Type 2 Patients Attending Out Patient Department at a University Hospital in New Delhi
... oral hypoglycemic agents to type 2 diabetic patients attending a university hos- pital, and to assess patient ...oral hypoglycemic agents were prescribed to the ...
10
Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice
... Results: After 20 weeks treatment with exenatide, mean HbA1c and body weight were significantly reduced from 8.4% to 7.7% and from 83.4 kg to 80.2 kg, respectively (both p < 0.001). Subjects with higher baseline ...
9
Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents
... oral hypoglycemic agents (glimepir- ide, acarbose and ...oral hypoglycemic agents was adjusted through the whole treatment period if the hypoglycemia occurred, based on the value of blood ...
9
Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population
... on drug safety and efficacy, drug- utilization patterns and clinical effective- ness in a “real-world” setting may differ substantially from the data provided from such trials. In particular, agent tolerabil- ity, ...
5
Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
... Abstract: Type 2 diabetes is one of the leading causes of morbidity and mortality, consuming a significant proportion of public health spending. Oral hypoglycemic agents (OHAs) are the frontline treatment ...
13
Hypoglycemic agents and potential anti-inflammatory activity
... various hypoglycemic drugs, which can contribute to improved clinical ...outcomes. Hypoglycemic agents exert their anti-inflammatory effects either by controlling hyperglycemia or directly, by acting ...
12
Oral hypoglycemic agents: do the ends justify the means?
... Historically, insulin has been the recommended treat- ment for GDM in the U.S. when dietary and lifestyle measures have failed. Today, randomized controlled tri- als support the efficacy and short-term safety of glybur- ...
10